Mucoadhesive microparticles can prolong the intestinal residence time of challenging molecules (such as proteins and peptides), thereby enhancing their oral absorption. Spray freeze drying provides several advantages over conventional drying methods and is therefore a promising approach to produce mucoadhesive microparticles intended for oral delivery of thermolabile biomolecules. However, spray freeze drying is a complex process, and slight changes in the formulation and process parameters viz., excipients, primary drying time, and primary drying temperature can significantly affect the critical quality attributes (e.g., particle size and particle flow) of the spray freeze dried microparticles. FTIR analysis indicated stabilizing interactions between the peptide and selected excipients. Notably, excipients that crystallized during drying generally yielded particles with superior mechanical integrity and flow properties. Comparative evaluation of formulations prepared by different drying techniques showed that mannitol and the peptide crystallized in both the spray freeze dried and freeze-dried samples, whereas they remained amorphous after spray-drying. In vitro release and ex vivo mucoadhesion studies demonstrated that spray freeze dried microparticles can sustain peptide release and enhance intestinal residence time. For spray freeze drying, drug release and retention correlated with particle size and matrix porosity, underscoring the importance of considering these parameters during formulation design. This research represents the first systematic development of a robust spray freeze drying process for mucoadhesive microparticles and provides the first detailed assessment of excipient effects on the critical quality attributes. The knowledge gained from this research can guide the design of spray freeze dried systems for different drug-delivery applications.